Tag: AdvaMed

, are required to be deducted over five years. The new provision delays the date when taxpayers must begin deducting those expenses over five years until after December 31, 2025. The five-year deduction requirement is especially hard for small and emerging companies, which are critical to driving innovation and improving patient outcomes. Research and development funding is expensive and hard for small companies to afford, given their narrow operating margins. In his letterto lawmakers earlier this month, Whitaker cited the example of Alva Health, a small company that wrote that the tax provision, if unfixed, would cause delays in getting ... Read more

 Today, the Advanced Medical Technology Association (AdvaMed) released the following statement from President and CEO Scott Whitaker regarding the Centers for Medicare and Medicaid Services (CMS) recission of the Medicare Coverage for Innovative Technologies (MCIT) final rule: “The MCIT rule was truly transformational for Medicare patients and doctors looking for life-saving and life-enhancing breakthrough medical technology to diagnose and treat diseases. We are disappointed in the decision made today to repeal that rule without an established pathway to quickly get these FDA-approved devices to seniors who need them most. We are committed to working with CMS and lawmakers on both ... Read more